Difference between revisions of "Montelukast (Singulair)"
Jump to navigation
Jump to search
(Created page with "Sometimes used in hypersensitivity protocols or as a premedication for antineoplastics highly likely to provoke and allergic reaction. Category:Drugs Category:Oral medi...") |
m |
||
| Line 1: | Line 1: | ||
| − | Sometimes used in hypersensitivity protocols or as a premedication for antineoplastics highly likely to provoke and allergic reaction. | + | Sometimes used in hypersensitivity protocols or as a premedication for antineoplastics highly likely to provoke and allergic reaction. Also used as a preventative medication for [[mast cell diseases]]. |
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
| − | [[Category: | + | [[Category:Antileukotrienes]] |
[[Category:Drugs FDA approved in 2003]] | [[Category:Drugs FDA approved in 2003]] | ||
Revision as of 17:56, 30 July 2018
Sometimes used in hypersensitivity protocols or as a premedication for antineoplastics highly likely to provoke and allergic reaction. Also used as a preventative medication for mast cell diseases.